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T. Resch,1* M. Lindh,2 N. Dias,2 B. Sonesson,1 P. Uher,2 M. Malina1 and K. Ivancev2Departments of 1Vascular Disease, and 2Radiology, Malmo¨ University Hospital, 205 02 Malmo¨, SwedenObjective. To evaluate a single centre experience of endovascular treatment of mesenteric ischemia caused by vascular
occlusion.
Design. Retrospective study.
Material and methods. Between 1995 and 2002 17 patients (12 females; mean age 61 years) with symptoms of bowel
ischemia were treated endovascularly for arterial occlusion. Vessels were evaluated with angiography and pressure gradient
measured. A mean gradient ofO20 mmHg or a stenosis ofO50% was considered significant. Patient data were recorded
prospectively and follow-up was supplemented with retrospective chart review. Fifteen patients had follow up imaging,
median 10 months (3–29 months) postoperatively. Median clinical follow up was 14 months (5–42 months).
Results. Recanalisation was successful in 16 patients (94%). The average number of stents used was 1.6 per patient. For one
patient recanalisation failed with subsequent SMA dissection. A celiac artery stenosis was stented but symptoms remained
postoperatively. Perioperative mortality was 5.8% (nZ1). 14/17 patients (82%) displayed symptom relief/improvement. Six
patients required secondary endovascular intervention; PTA (nZ3); stent/stentgraft (nZ3). Two of these patients required
a third procedure. 4/6 patients that underwent secondary intervention were asymptomatic and of recurrent stenosisO75%
and a gradient O15 mmHg mean pressure gradient on imaging. Two patients were treated because of a combination of
angiographic findings and/or significant pressure gradient combined with clinical symptoms.
Conclusions. Endovascular treatment of mesenteric ischemia due to vessel occlusion is feasible with acceptable short-term
results and limited complications. Most patients experience relief/improvement of symptoms. A significant number of
patients might need endovascular re-intervention because of restenosis.Keywords: Superior mesenteric artery; Mesenteric ischemia; Endovascular; Recanalisation.Introduction
Occlusive mesenteric ischemia (MI) can be divided
into acute and chronic forms. Whereas the latter
carries an excellent prognosis with low operative
mortality and long-term survival rates of 50–60% if
treated by surgical techniques, the former is associated
with high operative mortality and very poor long-term
results.1,2 The standard of care for MI previously has
been open surgical repair, but over the last 15 years the
development of percutaneous transluminal angio-
plasty (PTA) and stent placement has introduced a
minimally invasive treatment option.3–8 Short-term
results after endovascular repair are promising but
long term durability is yet to be proven. The
experience of endovascular treatment in patientsing author. Timothy Resch, MD PhD, Department of
o¨ University Hospital, Forstadsgatan, 205 02 Malmo,
: timothy.resch@home.se
0199 + 05 $35.00/0 q 2004 Published by Elsevier Ltd.with complete vessel occlusion is so far mostly limited
to case reports and small series.9–11
The purpose of this study is to evaluate a single
centre experience of endovascular treatment of chronic
and emergency mesenteric ischemia caused by com-
plete vascular occlusions.Material and Methods
All patients (nZ17) treated endovascularly for MI
caused by occlusion of one or more of the three main
mesenteric arteries between May 1995 and December
2002 were included. We previously reported on three
patients with arterial occlusion who underwent
endovascular treatment11 and these are included in
the present analysis. All patients were treated at our
hospital, which is a tertiary vascular referral center
with a catchment area of over one million people. The
patients presented with chronic (O2 weeks) or rapidlyEur J Vasc Endovasc Surg 29, 199–203 (2005)
doi:10.1016/j.ejvs.2004.11.004, available online at http://www.sciencedirect.com on
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mia with varying duration (Table 1). All patients
underwent diagnostic mesenteric digital subtraction
angiography. The patency of the mesenteric vessels
was evaluated by measuring the degree of cross-
sectional stenosis and the pressure gradient across the
lesion. A mean gradient ofO20 mmHg or a stenosis of
O50% was considered significant in the presence of
corresponding clinical symptoms. All pre-, per- and
post procedural data were entered in a computerized
data set and follow-up was supplemented with retro-
spective review of patient charts. No uniform follow-
up protocol was utilized, but patients were followed at
the discretion of the treating physician with clinical
examinations, duplex ultrasound or angiography.Recanalisation technique
Patients are preferably treated under general anesthe-
sia (in the current series two patients were treated in
local anesthesia). Access is gained through the
common femoral arteries and, if necessary, through
the right brachial artery (nZ6) using standard Seldin-
ger technique. The anatomy is established by abdomi-
nal aortogram in anterior–posterior and lateral views.
After identifying the origin of the occluded mesenteric
artery, an attempt was made to cross the occlusion
from below, using a Simonds shape catheter and 0.035
guide wire (Terumo Sweden AB, Sweden). If this
failed, an attempt was made at using the same
technique from the arm with a 4F Headhunter catheter
(COOK Europe, Bjaereskov, Denmark) and 0.035 guide
wire. Usually, recanalisation was obtained from belowTable 1. Patient demographics and presenting symptoms
Pt # Age Gender Comorbid
1 79 F 0
2 70 M 0
3 70 M 0
4 33 F HT
5 42 F HT
6 60 F HT
7 62 F HT, CAD
8 46 M CAD
9 53 M HT
10 75 F HT
11 85 F HT, CAD
12 61 F HT, CAD
13 71 F 0
14 39 F 0
15 66 F 0
16 47 F 0
17 78 M HT,CAD,R
M, Male; F, female; HT, hypertension(drug treatment); CAD, coronary a
dependent); RI, renal insufficiency (S-CreatinineO150 mmol/l); WL, w
superior mesenteric artery; IMA, inferior mesenteric artery; CA, coelia
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Occasionally a 0.014 gold-tip glide wire (Terumo
Sweden AB, Sweden) has been more successful.
Passing the occlusion with a 0.014 guide wire allows
a 1.5 mm coronary balloon to be placed through the
Simonds catheter further across the lesion, in order to
accomplish a canal. A 4F guide catheter (Terumo
Sweden AB) then was passed over the guide wire and
a stable 0.035 wire, such as TAD wire (Tyco Healthcare
Norden AB, Sweden) or Rosen wire (COOK Europe,
Bjaereskov, Denmark) was inserted. Further pre-
dilatation is performed using 4–5 mm standard PTA
balloons. Repeated angiographies are performed to
confirm the recanalisation and select a stent of
appropriate length Balloon-expandable stents were
used for the SMA and self-expandable if an extension
was required. Stent-grafts were used only when there
was a recurrence of stenosis. Self-expanded stents
have also been used on occasion because of inad-
vertent dissection of the main superior mesenteric
artery trunk. A 6F sheath (COOK Europe) was passed
across the occlusion and the stent deployed according
to the anatomy. The number of stents placed was
determined by the length of the occlusion, usually 2–
3 cm. Further dilatation, up to 8 mm, was carried out
in case there was a persistent mean pressure gradient
above 12 mmHg (Figure). Pressure gradient was
measured by placing a catheter in the aorta and
another 4F catheter placed in the SMA beyond the
recanalised segment such that pressures were
recorded simultaneously. The mean pressure was
defined as the area beneath systo-diastolic variations
during 5 cardiac cycles. Our experience from treating
renal artery stenosis was that any mean pressureity Symptoms Duration
(weeks)
Occluded
vessels
WL, PP 22 SMA
P 1 CA,SMA,IMA
P 1 CA,SMA,IMA
WL, PP 52 SMA,IMA
WL, PP 14 CA,SMA
WL, PP 52 CA,SMA
WL, PP 2 SMA
P, H 1 SMA
P 1 SMA,IMA
WL, PP 9 SMA,IMA
PP 1 SMA
WL, PP 6 CA,SMA
WL, PP 26 SMA
WL 2 SMA
WL, PP 26 CA,SMA
WL, PP 78 SMA
I,D PP 1 CA,SMA,IMA
rtery disease (angina, previous MI); D, diabetes (insulin/noninsulin
eight loss; PP, postprandial pain; P, pain; H, hematemesis; SMA,
c artery (column depicts only completely occluded vessels).
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recurrence of stenosis following PTA and a 12 mmHg
mean pressure gradient was associated significantly
with renal artery stenosis. In the superior mesenteric
artery we found that, despite complete angiographic
resolution of the lesion, there was often a residual
pressure gradient. Thus we empirically arrived at an
upper limit of 12 mmHg mean pressure gradient as
clinically significant. Completion angiography was
performed to evaluate the peripheral bed of the small
bowel circulation. A bolus dose of 3000–5000 IU of
Heparin was given during the procedure and
additional Heparin administered to achieve an acti-
vated clotting time of 200–300 s.Results
Seventeen patients (12 females), mean age 61 years
(range 33–85), were treated for complete arterial
occlusion with endovascular recanalisation (Tables
(1) and (2)) and are included in this analysis. Nine
patients presented as an emergency. One of these had
previously undergone an unsuccessful attempt at
superior mesenteric artery (SMA) recanalisation at a
nearby hospital, resulting in vessel dissection and
deteriorating symptoms. The underlying diagnosis
was atherosclerosis in all but one patient, who suffered
from Takayashus arteritis. In several patients more
than one of the main mesenteric branches was
occluded and remaining vessels were stenosed (Table
1).
Primary recanalisation (defined as achievingTable 2. Endovascular treatment and post-treatment result
Patient # Endoluminal device Remainin
SMA CA SMA
1 S –
2 S!2
3 S 0
4 SG 0
5 S 0
6 SCSG 0
7 SCSG 0
8 S!3 0
9 S 0
10 S –
11 S!3 0
12 S SG 0
13 S 0
14 SCSG SG 0
15 S 0
16 S!2 0
17 S 0
SMA, superior mesenteric artery; CA, coeliac artery; S, stent; SG, stent
stenosis was missing from the operative note, Patient #1 died intra-opreconstitution of the flow to the SMA without any
remaining stenosis) was achieved in 16 patients (94%).
The average number of stents used was 1.6 per patient
(Table 2). In one patient with chronic symptoms, the
attempt at recanalisation failed and caused a dissec-
tion in the SMA. A tight celiac artery stenosis was
stented but the patient’s symptoms remained symp-
toms postoperatively. One patient with acute ischemia
died intra-operatively giving a perioperative 30-day
mortality rate of 5.8%. This patient had undergone an
attempt at SMA recanalisation at a nearby county
hospital resulting in extensive dissection of the artery.
During this procedure the patient suffered cardiac
arrest and underwent successful cardiopulmonary
resuscitation. The patient was then transferred to this
centre and underwent successful SMA recanalisation
and stenting. However, the subsequent laparotomy
showed extensive, irreversible small and large bowel
ischemia. A further patient developed embolisation
into the ileo-colic artery during SMA recanalisation. A
coronary stent was placed in the ileo-colic artery and
the patient recovered uneventfully. In yet another
patient open brachial arteriorraphy was required
because of bleeding. This patient suffered neuralgic
pain and paresthesia corresponding to the injury,
which persisted at the latest follow-up (45 months
postoperatively).Follow up
No patient was lost to follow up. Two patients were
followed up at another hospital, by the referring
physician. Fifteen patients had angiographic org stenosis (%) Remaining mean pressure gradient
(mmHg)
CA SMA CA
– – –
0 0
10
24
10
3
19
10
0
0 – –
–
– 0 –
17
– 10 –
14
16
15
-graft, ‘–’ indicates that a statement of remaining gradient and/or
eratively therefore no gradient was measured.
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(3–29 months) postoperatively. Some patients had
further clinical follow up after the last imaging and
median clinical follow up was 14 months (5–42
months). Symptom relief or improvement, as evalu-
ated by treating physician and by patient perception,
was attained in 14/17 pts (82%). There was no
correlation between the remaining gradient and the
relief of symptoms. Six patients required endovascular
revision either by PTA (nZ3) or PTA and stent/stent-
graft (nZ3). Two of these patients subsequently
required a further procedure. Four of the six patients
were asymptomatic and treated on the basis of
angiographic findings. Two patients were treated
because of a combination of angiographic findings of
restenosis and/or significant pressure gradient in
combination with clinical symptoms of pain and
weight loss. One patient experienced increasing pain
postoperatively. Repeat angiography with pressure
measurement revealed completely normal findings.
The patient also displayed weight gain and the
atypical pain was not ascribed to ischemia. One
patient who had undergone small bowel resection
due to ischemia several years before the endovascular
treatment, developed severe abdominal pain 17
months after SMA recanalisation. Both angiography
and exploratory laparotomy displayed normal find-
ings. Pain resolved spontaneously.Discussion
Endovascular treatment of MI has been reported
previously but recanalisation of complete occlusions
has only been described in a limited number of
patients. To our knowledge, this is the first report to
describe a significant number of patients with mesen-
teric artery occlusions that were consistently treated
by endovascular recanalisation.
To date the gold standard for treatment of occlusive
mesenteric ischemia has been operative repair. Most
reports advocate reconstitution of flow to as many
visceral arteries as possible by branched arterial grafts
during open repair.1,12 However, some reports have
shown equally good results when using a single vessel
approach, preferably the SMA.1,13 A possible expla-
nation for this is the confinement of postprandial
hyperemia to the SMA, in combination with the
usually extensive collateral pathways, especially in
chronic ischemia. Another reason for advocating a
single vessel approach in endovascular treatment
relates to anatomical features in the abdominal cavity,
such as the median arcuate ligament bearing down on
the celiac trunk, which might lead to increase wear onEur J Vasc Endovasc Surg Vol 29, February 2005stents in this location. The results of open repair is
good in patients with chronic ischemia and most
authors report technical success of 100% with relief of
symptoms in all cases.14 However, patients suffer
complications in up to 30% of cases and the perio-
perative mortality rate is around 10%. Patency rates
range from 75 to 100%. When considering acute onset
mesenteric ischemia the results are not as good and
mortality rates between 40 and 60% are often
reported.2,15,16 This may be due to the lack of collateral
pathways as well as worse co morbidities in these
patients.
The endovascular approach to mesenteric occlusive
diseases has existed for more than 20 years. Initially
percutaneous endoluminal angioplasty (PTA) was the
favored treatment.3,17,18 Primary technical success
rates ranging from 84 to 100% in combination with
high degree of symptom improvement have been
shown.5,14,19 Perioperative mortality rates from 0 to
11% are comparable to open repair and complication
rates are somewhat lower. The main problem has been
restenosis and the common need for secondary
endovascular procedures, reported in a third of cases
during follow up.5,14,19 Very few series have used
contemporary endovascular management with stents
to treat MI. A retrospective study from the Cleveland
Clinic in 200114 compared a series of patients that
underwent endovascular treatment (mostly stenting)
primarily for vessel stenosis, not occlusions, with a
group of patients undergoing open revascularisation.
They found similar complication and mortality rates
for each group and no reduction in hospital stay for the
endovascular group. No difference was found in
restenosis rates during follow-up, but the endovascu-
lar patients had higher incidence of symptom recur-
rence. The authors reasoned that this might be due to
the technique of single vessel recanalisation in the
endovascular patients, but they could find no statisti-
cal difference between the number of vessels treated in
the open patients to support this hypothesis.
In our study the technical success rate was high
despite the fact that all patients underwent recanalisa-
tion of completely occluded vessels. In addition, eight
out of the 17 patients experienced rapidly deteriorat-
ing symptoms prior to intervention (!2 weeks) which
is associated with more frequent complications. The
perioperative mortality rate of 6% is comparable to
open repair. Our only fatality was a patient who
initially presented at another hospital where the first
endovascular treatment failed. The patient was
referred to us and successfully recanalised but
succumbed to irreversible ischemia. Some authors
have expressed fears that recanalisation might create
dissection or peripheral embolisation and have
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series suffered such a complication. An embolus in the
ileo-colic branch during the procedure was corrected
by stent placement without postoperative clinical
sequele.
The drawbacks of this study are those to be
expected by a retrospective analysis. The indication
for treatment, both with regard to degree of post
intervention pressure gradient as well as definition of
when to intervene during follow up in asymptomatic
patients has not been fully standardized. No standar-
dized follow up protocol has been used allowing for
precise evaluation of patency rates with life table
method. Decisions regarding indications for angio-
graphic or other follow up imaging, such as duplex
scanning, were made by the treating physician. Our
intention in the future is to establish a prospective
protocol for these patients with strict follow up
intervals and indications for reintervention.
In conclusion, we have found that endovascular
treatment of chronic and subacute mesenteric ische-
mia due to vessel occlusion is feasible with acceptable
short-term results and limited complications. Most
patients experience relief or decrease of symptoms
using this single vessel approach. A significant
number of patients might need endovascular reinter-
vention due to restenosis. Further studies with
prospective follow-up are needed to determine the
long-term efficiency of this treatment modality and its
final place in the treatment of mesenteric ischemia.References
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